个股论点

围绕单一股票的投资逻辑与仓位表态 · 共 2504 条 · 滚到底自动加载更多

  1. 个股论点 $NVDA$MRVL

    黄仁勋称MRVL是下一家万亿美元公司,作者持有Marvell。

    $NVDA 黄仁勋: “$MRVL 是下一家1万亿美元公司,女士们先生们。” Marvell 目前市值1910亿美元。 我持有 Marvell……但我们对 Jensen 带来5倍空间有多大信心?

    英文原文

    $NVDA Jensen Huang: “ $MRVL the next $1T company ladies and gentlemen “. Marvell is currently trading at $191B. I have positions in Marvell… but how much faith do we have in Jensen for the 5x? https://t.co/II4DTZ5Z9D

  2. 个股论点 $HPS.A

    称Hammond是加拿大变压器瓶颈多头。

    回复 @AliTava2020:$HPS.A 是我在加拿大的变压器瓶颈多头。 它有很大的积压订单,所以多年收入可见度高,并且在干式变压器中市场份额高。 美国 Production Act 可能会让 Hammond 这类公司受益。

    英文原文

    @AliTava2020 $HPS.A was my Canadian long for transformers bottleneck. Pretty large backlog, so multi-year revenue visibility, high market share over dry transformers. US production Act likely benefiting companies like Hammond.

  3. 个股论点 $AAOI$SNDK

    称AAOI是最喜欢的美国光学多头,2027年上半年到下半年或是拐点。

    我确实说过 $AAOI 是我最喜欢的美国光学多头…… 今天 +20.1%。 如果你想找下一个 $SNDK,你正在看着它。 我认为2027年上半年进入下半年时,可能会是光子学玩家的巨大拐点。 我们只是稍微早了一点,现在才进入2026年下半年,而大家还在……

    英文原文

    I did say $AAOI was my favorite US optical long... +20.1% today. If you want the next $SNDK, you're looking at it. I think H1 entering H2 2027 will likely be that massive inflection point for photonics players. We're just a tad early entering H2 2026 while everyone is https://t.co/0JuWJFrz32

  4. 个股论点 $SIVE

    称没有自己SIVE也会很好,只是可能由机构持有。

    回复 @JohanAn37323972:$SIVE 没有我也会很好。 唯一的区别是,它现在可能已经90%由机构持有,而不是由美国散户持有。

    英文原文

    @JohanAn37323972 $SIVE would do just fine without me. The only difference is it would be 90% institutional owned by now instead of US retail.

  5. 个股论点 $SIVE$JBL

    称若SIVE跌回低位会考虑发基金买下,因JBL放量和更多客户在路上。

    回复 @Path21Mil:如果 $SIVE 真跌到那些水平,我可能会考虑发一个基金直接把它买下来,哈哈。 考虑到 $JBL 可插拔放量和更多光收发器客户正在推进,我不认为它还能再回到那里。 也不确定他们是在为谁分析,瑞典人不……

    英文原文

    @Path21Mil I’d probably consider launching a fund to just buy out $SIVE if it reached those levels lol. Don’t think it’s possible to go there again, given $JBL pluggable ramp and more optical transceiver customers underway. Also not sure who they’re analyzing for, Swedish folks don’t

  6. 个股论点 $XFAB

    认为XFAB受2025周期低迷拖累,接近账面和重置价值;Melexis也可能接近汽车周期底部。

    回复 @MatteoDeDycker:据我所见,2025年是周期性低迷。$XFAB 已经被拖累,因为它接近市净率价值,也低于我个人估算的实际资产重置成本。 对于 Melexis,也是在猜我们接近汽车周期底部,传统业务拖累有点像……

    英文原文

    @MatteoDeDycker From what I’ve seen, cyclical slump 2025. $XFAB was already dragged down, since it’s close to P/B value and lower than actual cost of asset replacement value from personal est. For Melexis, it’s also a guess we’re near the bottom of automotive cycle for legacy drag kinda like https://t.co/qDjspQB3yd

  7. 个股论点 $XFAB$NVDA$NVTS

    围绕XFAB、800VDC、GaN/SiC和西方供应链做移动端思考。

    一些手机上随手写的关于 $XFAB 的思路: 1. $NVDA 推动 800VDC,寻找 GaN/SiC 玩家和功率半导体。 2. $NVTS 和其他受益于 $NVDA 推动的 fabless/fab-lite 公司,可能使用代工模式。 3. 相比亚洲供应链,我更关心西方供应链……

    英文原文

    Just some mobile shower thoughts around $XFAB and train of thought: 1. 800vdc $NVDA push look for GaN/SiC players / power semis. 2. $NVTS and other fabless/fab-lite beneficiaries of $NVDA push probably use foundry models 3. care more about Western supply chains over Asia,

  8. 个股论点 $AAOI$AMZN$MSFT

    称AAOI是当前美国市场最喜欢的光子学敞口。

    $AAOI 实际上是我现在在美国市场最喜欢的光子学敞口。 去年我在28美元以低仓位做多,当时我猜它们正在与 $AMZN 和 $MSFT 认证。 业绩后约70美元时我有高信念,因为它们宣布了1.6T 和其他批量订单……

    英文原文

    $AAOI is actually my favorite photonics exposure in the US market right now. I went long last year with low sizing at $28, back when I guessed they were qualifying with $AMZN and $MSFT. High conviction post earnings at ~$70, when they announced 1.6T and other volume orders with

  9. 个股论点 $LPK

    称LPK论点不变,等待放量开始。

    回复 @aiizisw77940 @talethdabm89:不是,$LPK 仍然一样,只是在等待放量开始。

    英文原文

    @aiizisw77940 @talethdabm89 Nope, it’s still the same with $LPK, just waiting on volume ramp to start.

  10. 个股论点 $SIVE$SNAP

    信任SIVE管理层,若像SNAP才会更激进维权。

    回复 @AsianbeBlazin:因为我相信 $SIVE 管理层自己知道该怎么做。 如果他们像 $SNAP 那样运营,我会更激进地做维权投资。

    英文原文

    @AsianbeBlazin Because I’m confident $SIVE management knows what to do by themselves. If they operated like $SNAP I’d be more activist.

  11. 个股论点 $SIVE

    高度认可SIVE管理层,并看好纳斯达克双重上市路径。

    回复 @_king142:不知道,只是把我的观点公开抛出来。 但到目前为止,我对 $SIVE 管理层极其、极其印象深刻。我认为他们很快通过 NASDAQ 双重上市走在正确道路上。

    英文原文

    @_king142 No clue, just floating out my opinion into the public. But I’m extremely, extremely impressed with $SIVE management so far. And I think they’re heading down the right path with NASDAQ dual listing soon.

  12. 个股论点 $SIVE

    认为SIVE因美国客户、股东和CHIPS支持而适合美国化。

    回复 @Noamneo_:$SIVE 是一个极其特殊的案例,因为它已经通过客户、股权结构、CHIPS Act 等拥有重大美国存在。 主要留在瑞典、面对一个试图阻碍其增长的本地市场,并不理想。 我不会说同样的迁址对其他公司也一定正确……

    英文原文

    @Noamneo_ $SIVE is an extremely singular case just because of major US presence already from customers, cap table, CHIPS acts, and others. Staying primarily in Sweden with a local market that tries to hinder their growth, isn’t ideal. I wouldn’t say the same redomestication is the right

  13. 个股论点 $SIVE

    主张SIVE应成为完整美国公司,纳斯达克上市是第一步。

    我认为 $SIVE 应该直接成为一家完整的美国公司,并把 NASDAQ 上市作为第一步。 > 美国股权结构/大型持股 + 已有美国 CHIPS Act 支持 > 更高估值溢价 + 并购机会 > 瑞典本地媒体来自深度亏损者的明显错误信息……

    英文原文

    I think $SIVE should just become a full American company, and use NASDAQ listing as the first step. > US cap table / large ownership + US CHIPS act support already > larger valuation premiums + M&A opportunities. > local Swedish media blatant disinformation from underwater

  14. 个股论点 $AAOI$SIVE

    随机预测一年后AAOI/SIVE/Foci/Shunsin市值。

    回复 @Batemanzm75:我来随便做一个一年后的预测: $AAOI - 700亿美元市值 $SIVE - 300亿美元市值 Foci - 150亿美元市值 Shunsin - 100亿美元市值

    英文原文

    @Batemanzm75 I’m gonna go ahead and make a random prediction in a year: $AAOI - $70B MC $SIVE - $30B MC Foci - $15B MC Shunsin - $10B MC

  15. 个股论点 $AAOI$SIVE$AXTI

    认为AAOI、SIVE、Foci、Shunsin当前风险收益最好。

    - $AAOI 120亿美元 - $SIVE 20亿美元 - Foci 28亿美元 - Shunsin 20亿美元 在我看来,这些通常是目前最好的风险/回报。之前我的很多答案,比如 $AXTI,已经涨了10倍,所以这次阵容不同。 $AAOI 是因为产能爬坡带来的2027年上半年荒谬收入预测,正在做所有事情……

    英文原文

    - $AAOI at $12B - $SIVE at $2B - Foci at $2.8B - Shunsin at $2B Usually the best risk/reward to me currently. Lot of my answers before like $AXTI already 10x’d, so different lineup this time. $AAOI due to absurd H1 2027 revenue projections from capacity ramp, doing everything

  16. 个股论点 $LITE$SIVE

    认为SIVE 60%毛利率显示极强定价权。

    回复 @ram_blings:不是1:1,但 $LITE 毛利率大约45-48%。 $SIVE 能有60%毛利率,是极强的定价权。 而且这还叠加在指数级增长的收入管线上……并且处在 CPO 超级周期刚开始的时候。

    英文原文

    @ram_blings Not 1:1 but $LITE gross margins are ~45-48%. Having 60% gross margins for $SIVE is extreme pricing power. And that’s on top of exponentially growing revenue pipelines… at the very beginning of the CPO supercycle.

  17. 个股论点 $SIVE

    SIVE称需求远超供应且未来60%毛利率,作者认为极度看多。

    天啊,这是我目前从 $SIVE 听到的最看多的内容。 来自财报电话会记录: “当需求远远超过供应时,我们不看竞争对手”(字面意思是他们生产的任何东西都会被买走)。 同时还有:“我们认为未来毛利率为60%”(极其……)

    英文原文

    Holy crap, this is the most bullish thing I’ve heard from $SIVE so far. From earnings transcripts: “We do not look at competitors when demand far outstrips supply” (literally anything they make gets bought) Along with: “We see 60% gross margins in the future” (incredibly https://t.co/6u3LSTQofy

  18. 个股论点 $SIVE$JBL

    极度看多SIVE,因前瞻增长77%、JBL放量确认和多个量产启动。

    回复 @DeJeff48985:极度看多 $SIVE。 我对自己持有名字的财报一向非常直白诚实。 我们从整个公司管线中看到了单季度77%的前瞻增长信号。 $JBL 放量确认。 然后还有多个量产爬坡开始……

    英文原文

    @DeJeff48985 Extremely bullish on $SIVE. I’m very brutally honest when it comes to earnings reports on the names I own. We got 77% forward growth indications from the entire company’s pipelines… over a single quarter. $JBL ramp confirmation. Then multiple volume ramp production starts

  19. 个股论点 $HPS.A

    Hammond变压器多头两个月上涨83%,需求可见度高。

    $HPS.A 接近两个月时间框架。 “天上的变压器”自那以后上涨83.3%。大黄蜂 go brrr? 但说真的,变压器需求可见度非常高,积压订单扎实,干式变压器市场份额高。 不算抛物线式上涨,但看起来是一个有吸引力的复利标的。

    英文原文

    $HPS.A is close is to a 2M timeframe. Transformers in the Sky are up 83.3% since. Bumblebee go brrr? But in all reality, transformers demand visibility is very high, solid backlog, high market share (of dry). Not exactly parabolic, but looks like a compelling compounder. https://t.co/bNGwjqfZ4M

  20. 个股论点 $AAOI$NVDA$AMD

    即使AAOI已130亿市值,因激光瓶颈和2027收入爬坡更看多。

    考虑到最近所有激光瓶颈,我实际上比 $AAOI 在20亿美元或60亿美元市值时,更看好现在130亿美元市值的 $AAOI。 我也认为市场错过了关于它可能与 $NVDA 或 $AMD 签订长期供应协议的分析师注释。 如果他们预测2027年上半年4.71亿美元……那是荒谬的爬坡。 当然,6亿美元 ATM 是短期压制。 只是等待时间的问题?因为这更多是能否跟上需求。 所以问题更多是他们能生产多少。 它大概是我现在持有的、最喜欢的美国本土光子学多头。

    英文原文

    I’m actually even more bullish on $AAOI at $13B MC given all the recent laser bottlenecks… Than I was back at $2B or $6B. I also think markets missed the analyst note around potential long term supply agreements with $NVDA or $AMD. If they’re projecting $471M in H1 2027… that’s absurd ramp. But of course the $600M ATM is a short term overhang. Just a matter of waiting time? Given it’s more about keeping up with demand… So more of a matter of how much they can make. Probably my favorite US-based photonics long stock now that I own.

  21. 长文重申SIVE是最有吸引力的CPO/光子学敞口,并列出客户、资金、上市和M&A催化。

    $SIVE 是我眼中最有吸引力的 CPO/光子学敞口。 针对错误信息:我没有卖出,也不打算卖出一股。 我确实认为它有一天会从约21亿美元成长为下一个800亿美元以上的 $LITE。 我个人也计划获得更多所有权,并支持它们的并购前景。 我相信财报电话会记录会非常正面。 过去几个月我们发现了很多线索:AlChip/Amazon 私募对 Ayar 有利,并暗示 $SIVE 进入 Trainium 4 设计;Wiwynn + Ayar 的 CPO 放量;$JBL 1.6T 光收发器与 Sivers 的放量比市场预期更快;O-Net 正在扩大与 $SIVE 的 ELS 努力;$YSS 收购 $SIVE 的 allspace 主要合作伙伴并把 Sivers 设计进太空防务主承包商;新的 CHIPS Act 资金;$POET 下半年放量及其新订单($SIVE 作为光源);关于 $AAPL 使用 $SIVE 激光用于下一代消费设备的信息;与 Lightelligence、Lightmatter、Celestial/$MRVL、Lightium、$AMD/$GFS、Ayar、可插拔 TAM、NASDAQ 上市、MSCI/Nasdaq OMX 纳入、M&A、$NOK 客户线索、$LITE 的 CW 瓶颈和 Win 产能协议等信息。 这些市场研究都发生在财报之前。任何财报结果只是对供应链映射的确认。 我不认为有人关心前一季度收入,因为 $SIVE 是一个极具吸引力的2027年多头,尤其是下半年以后。 我只看几件事:整体光子学超级周期的 TAM 扩张(如光引擎、ELS、可插拔),来自并购或业务发展的机会;现有客户的放量预期;NASDAQ 上市时间线,以获得更多流动性支持并购;以及 CPO/可插拔的新客户信号。

    英文原文

    $SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support their M&A prospects. I believe earnings transcripts will be strongly positive. As in the part few months we’ve discovered: > AlChip/Amazon private placements, which is positive for Ayar -> $SIVE implying Trainium 4 design in > Wiwynn + Ayar CPO scale up > $JBL 1.6T optical transceiver ramp with Sivers incoming faster than markets expected (with relatively dramatic moat + demand as much as they can produce) > O-Net scaling up ELS efforts with $SIVE > $YSS acquisition of $SIVE allspace lead partner, designing Sivers into Space defense primes > New CHIPS ACT funding for $SIVE > $POET H2 volume ramp and their new $50m -> $500m order (with $SIVE as light source) > information discovery around $AAPL using $SIVE lasers for next gen consumer devices > information discovery around links to Lightelligence (went public $10B+ MC) + Lightmatter as likely customers. > Celestial volume ramp with $MRVL indicators. > new customers working on TFLN with $SIVE like Lightium > $AMD going with $GFS for CPO, and GFS listing sivers as one of two laser suppliers > Ayar removing $MTSI / $LITE from their website and signaling $SIVE as primary source/sole source > Ayar raising $500m for volume ramp (intel, Mediatek, Nvidia, amd etc) > pluggable TAM expansion signaled from 2025 annual report > Nasdaq listing expected soon > MSCI small cap index / Nasdaq omx inclusion, making Blackrock, Vanguard and others passive buyers > M&A signaled from 2025 annual report + 2 new board members that have experience in that area > $NOK as likely customer from 2025 annual report. > $LITE getting cw bottlenecked from EML contracts, $SIVE signaling capacity agreements in place with Win, making the a likely bottleneck owner + chokepoint in CPO sector. All of this market research was done before earnings. Any results is just confirmation of supply chain mapping done. I don’t think anyone cares about former quarter revenue since $SIVE is an exceptionally compelling 2027 long, especially H2 onward. Only thing I’m looking at are: > TAM expansion of the overall photonics supercycle (eg. optical engine, ELS, pluggables) either from M&A or developments > volume ramp expectations from existing companies > Nasdaq listing timelines for more liquidity to support their M&A efforts > any new customers signaled for CPO/Pluggables

  22. 个股论点 $XFAB

    认为XFAB在15亿美元市值很有吸引力,是美国唯一高量SiC代工厂。

    我真心认为 $XFAB 在15亿美元市值非常有吸引力,尽管最近波动很大。 根据 NIST 文件,它们是美国唯一的高量 SiC 代工厂。 这让它们成为极其“关键的基础设施”……这是美国政府原话。 而且它们是第一个综合……

    英文原文

    I genuinely think $XFAB is very compelling at $1.5B MC, despite recent volatility. Per NIST filings stated they were the only high volume SiC foundry in America. Making them extremely “critical infrastructure”… Verbatim from the US Gov. And they’re the first comprehensive https://t.co/4OGXctOv5h

  23. 个股论点 $XFAB$NVDA$NOK

    感谢路透和彭博中性报道XFAB,但强调800VDC、NVDA/NOK评估和CHIPS催化。

    感谢路透和彭博今天对 $XFAB 更中性的报道。 不过如果能更多聚焦我提出的结构性 thesis 会更好…… 围绕 800VDC 功率半导体的 $NVDA 敞口,以及正在进行的 $NVDA / $NOK 光子学评估。 以及 CHIPS Act 半导体主权作为近期催化。 而不是围绕新型信息综合带来的波动。 你知道的,我花很多时间看监管文件,寻找市场错过的有吸引力东西。

    英文原文

    Appreciate the more neutral coverage by Reuters and Bloomberg on $XFAB today. Although it would be nicer to focus more on the structural thesis presented… Around 800 vdc power semis $NVDA exposure + with ongoing $NVDA / $NOK evaluations for photonics. And around CHIPS Act semiconductor sovereignty as the near term catalyst. Rather than around volatility from novel information synthesis. I spend a lot of time looking at regulatory filings to find compelling things market missed you know…

  24. 个股论点 $XFAB$RPI$NVDA$NOK$SOI$NVTS$POWI$WOLF

    长文反驳XFAB是迷因股,强调CHIPS资金、SiPH评估、800VDC功率半导体和低估值。

    媒体兄弟……$XFAB 怎么会是迷因股? 这次能不能不要重复 $RPI 的错误? 它们字面上因为自身关键性正在获得欧盟 CHIPS Act 资金。 并且有 $NVDA / $NOK 在评估它们的 SiPH 业务,同时它们以约1.28倍低市净率交易。 这让我想起 $SOI:低市净率,但传统业务拖累之外有高增长垂直领域。 $XFAB 下周在 CHIPS Act 2 蓝图中被明确提到,而该蓝图聚焦光子学。 主要收入爬坡围绕 $NVDA 推动 800VDC 带来的功率半导体。 所以 $NVTS、$POWI、$WOLF 等最近都在起飞。 市场只是错过了 $XFAB,因为它是功率半导体里知名度较低的代工厂……但美国商务部两年前就指出它是美国唯一高量 SiC 代工厂。 我只是刚好指出了这些连接。 不要因为你不理解某件事,就把它叫作“迷因股”,说价格脱离基本面。

    英文原文

    Bro media… how is $XFAB a meme stock? Can you not repeat the same mistake with $RPI this time? They’re literally getting CHIPS ACT funding from the EU because of how critical they are. And have $NVDA / $NOK evaluating their SiPH side of things, while they traded at a low ~1.28 P/B. This just reminded me of $SOI low p/b but high growth verticals out of legacy segment drag. $XFAB was literally mentioned for CHIPS ACT 2 next week in the blueprints… Which focuses around photonics. The main revenue ramp was around power semis with $NVDA pushing 800 vdc. So $NVTS, $POWI, $WOLF and everyone have been taking off recently. Markets just missed $XFAB, because they’re a lesser known foundry in power semis…But US Dpt. Of commerce pointed them out as the only high volume SiC foundry in the US 2Y ago. I just happened to point out the connections. Just because you don’t understand something, don’t just go call it a “meme stock” with price detached from fundamentals.

  25. 个股论点 $XFAB$NVDA$NVTS$POWI

    XFAB兼具光子学和功率半导体,EU CHIPS Act 2是催化。

    $XFAB(光子学 + 功率半导体)是一个有趣的多头想法,市值12.8亿美元,我已经建仓。 考虑到 EU CHIPS Act 2 今天是欧洲光子学玩家的催化。 > 通过 $NVTS + $POWI,拥有 $NVDA 推动下的 800VDC 功率半导体敞口。 > 硅光子 / CPO……

    英文原文

    $XFAB (photonics + power semis) is an interesting long idea at $1.28B MC, that I took positions in. Given EU CHIPS act 2 is today as the catalyst for European photonics players. > 800 VDC power semi exposure to $NVDA push through $NVTS + $POWI > Silicon Photonics / CPO https://t.co/AZFFLbQk8O

  26. 个股论点 $XFAB$NVDA$NVTS

    指出自己建仓的是XFAB,兼具Nvidia功率半导体和光子学敞口。

    这就是我个人喜欢并持仓的公司。 绝对不是 $DPZ。 但某种程度上让我想起 Soitec。 功率半导体 / SiPH 两边都对 Nvidia 生态有敞口。 光子学方面正在通过 Nvidia 评估。功率半导体敞口通过 NVTS 和 POWI,约1.29倍市净率,欧盟 CHIPS Act 受益者。美国 CHIPS Act 资助也在进行中。 约12.8亿美元市值,应该会受益于今天作为催化的 EU CHIPS Act 第二轮。

    英文原文

    This was the company i personally liked + have positions in. Definitely not $DPZ. But kinda me of Soitec in a way. Power semi / SiPH exposure both to Nvidia ecosystems. Photonics side eval through Nvidia right now. Power semi exposure through NVtS and powl, ~1.29 p/b, EU chips act grantee. US chips act grant ongoing. ~$1.28B MC, should be beneficiary of eu chips act round 2 today as a catalyst

  27. 个股论点 $SIVE$AAOI

    认为SIVE是最有吸引力的CPO敞口,核心激光供应商多已数百亿美元估值。

    $SIVE 是我看来最有吸引力的 CPO 敞口股票。 尽管有波动。 在多年后下一次光子学架构转变之前,你可能不会再找到这样的东西。 在核心激光供应商中,它们都已经是数百亿美元级别? $AAOI = 150亿美元 Furukawa……

    英文原文

    $SIVE is the most compelling CPO exposure stock to me. Despite the volatility. You probably won’t find something like this again until the next architectural shift in photonics years later. Out of the core laser suppliers, they’re all tens of billions? $AAOI = $15B Furukawa https://t.co/bPCZdDKXhZ

  28. 个股论点 $SIVE$POET$JBL$AEVA

    用私有CPO玩家估值论证SIVE作为上游激光瓶颈应获得更高估值。

    给试图做 $SIVE 估值分析的人: Ayar、Celestial、Lightmatter、Lightelligence 今天大概估值约40亿到150亿美元以上。 Sivers 市值约26亿美元,而且很可能是它们所有人的上游激光供应商。 我甚至还没把 Poet、TFLN 相关的 Hyperlight/Lightium,或 Jabil 和其他未披露可插拔玩家纳入估值分析。 也没包括 CHIPS Act 合同、Apple/Nokia 关系,或 Aeva 等人形/物理 AI 业务。 散户对私募市场不太熟悉……但这些公司都被视为前沿 CPO 玩家,并且估值和规模都在迅速增长。 所以我预计 $SIVE 应该获得类似甚至更高估值,因为它有激光瓶颈溢价。尤其是在它通过并购扩展 TAM 和收入之后。 下个月 BlackRock/Vanguard/MSCI/NASDAQ 新资金流入会随时间缩小差距。 但 NASDAQ 上市可能才是真正给 Sivers 溢价的因素。

    英文原文

    For people trying to do valuation analysis on $SIVE. Ayar, Celestial, Lightmatter, Lightelligence are probably valued probably ~$4B-15B+ today. Sivers is ~$2.6B MC and they're likely upstream laser for them all. I'm not even including Poet, TFLN links like Hyperlight/Lightium, or pluggables like Jabil + other undisclosed players in valuation analysis. Or their other segments like CHIPS Act contracts or Apple/Nokia relationships. Or humanoid/physical AI segments with Aeva + others. Retail aren't as familiar with private markets... But these companies are all considered the frontier CPO players, and are growing valuations/scaling rapidly. So, I'd expect $SIVE to command similar if not higher valuations given laser chokepoint premiums. Especially after they pull off M&A to TAM expand revenue. New Blackrock/Vanguard/MSCI/NASDAQ inflow next month helps close that gap over time. But NASDAQ listing is probably what gives Sivers a premium.

  29. 个股论点 $SIVE$AXTI$LITE

    称SIVE仍极早,机构被动流入和NASDAQ上市将带来更多美国机构。

    你听了吗,朋友? $SIVE 还极其早期。 我们下周将首次看到大量机构流入(BlackRock、Vanguard、MSCI、NASDAQ)。 然后,再叠加很快的 NASDAQ 上市,以及更多美国机构进入。 这就是处在 $AXTI 或 $LITE 这类名字最早期时的感觉。 而且现在仍处在主要机构资本尚未进入流通盘、CPO 超级周期尚未爬坡之前。

    英文原文

    Did you listen anon? $SIVE is extremely early. And we’re about to see a ton of institutional inflow (Blackrock, Vanguard, MSCI, NASDAQ) next week for the first time. Then, couple that with NASDAQ listing soon, with even more US institutions entering. This is what it’s like to be in a name like $AXTI or $LITE at the very beginning. And this is still at a point before major institutional capital hit the float or CPO supercycle has ramped.

  30. 个股论点 $SIVE

    列出SIVE受益于NASDAQ指数纳入、BlackRock/Vanguard被动买入、美国政府支持等新事件。

    $SIVE 是这个周末全新事件的最大受益者: 1. Sivers 新纳入 NASDAQ 指数(OMX Stockholm): Vanguard 和 BlackRock 都是新的被动资金流入。 加上下一周的 MSCI,对现有流通盘将有约6000万美元以上纯买入压力。 2. 美国政府和瑞典签署联合技术合作协议。 $SIVE 是少数 CHIPS Act 受益者之一,尤其是在瑞典。 如果你不记得,它们上周还获得了另一笔660万美元 CHIPS Act 奖励。 这让 $SIVE 得到美国政府大力支持,并对其至关重要。 简而言之:来自 BlackRock/Vanguard 这类最大美国机构的新被动资金流入,叠加美国政府支持。 这对基本面(来自五角大楼供应链的收入/TAM)和 BlackRock/Vanguard/MSCI/NASDAQ 流入都利好。 极度看多。

    英文原文

    $SIVE is the largest beneficiary of brand new events this weekend: 1. Sivers new NASDAQ index inclusion (OMX Stockholm): Both Vanguard and Blackrock are new passive inflows. With ~$60M+ pure buying pressure inflow, into existing float, together with MSCI next week. 2. US Gov and Sweden sign agreement for joint tech collaboration. $SIVE is one of the few CHIPS act recipients, and especially in Sweden. And if you don’t remember, they received another $6.6M CHIPS act award last week. Making $SIVE heavily supported + critical to the US government. - TLDR: New passive institutional inflow from your largest US institutions like Blackrock/Vanguard. Compounded with US government backing into $SIVE. Over the weekend. Beneficial for fundamentals (revenue/TAM from Pentagon supply chains) and inflow from Blackrock/Vanguard/MSCI/NASDAQ. Extremely bullish.